Cargando…
Adenine base editing to treat progeria syndrome and extend the lifespan
Hutchinson-Gilford progeria syndrome (HGPS) is an exceedingly rare and hitherto incurable and fatal disease marked by accelerated aging simultaneously affecting a number of organs. Most cases of HGPS are caused by a single copy of a specific single-nucleotide mutation, c.C1824T, in the LMNA (lamin A...
Autor principal: | Musunuru, Kiran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302045/ https://www.ncbi.nlm.nih.gov/pubmed/34308436 http://dx.doi.org/10.20517/jca.2021.10 |
Ejemplares similares
-
Single-Dose CRISPR/Cas9 Therapy Extends Lifespan of Mice with Hutchinson-Gilford Progeria Syndrome
por: Beyret, Ergin, et al.
Publicado: (2019) -
Genetic reduction of mTOR extends lifespan in a mouse model of Hutchinson‐Gilford Progeria syndrome
por: Cabral, Wayne A., et al.
Publicado: (2021) -
Boosting ATM activity alleviates aging and extends lifespan in a mouse model of progeria
por: Qian, Minxian, et al.
Publicado: (2018) -
In Vivo Base Editing Rescues Hutchinson-Gilford Progeria Syndrome in Mice
por: Koblan, Luke W., et al.
Publicado: (2021) -
Transient expression of an adenine base editor corrects the Hutchinson-Gilford progeria syndrome mutation and improves the skin phenotype in mice
por: Whisenant, Daniel, et al.
Publicado: (2022)